Global Emphysema Treatment Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the emphysema treatment market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Emphysema Treatment Market In The Period 2029-2034?

The emphysema treatment market has experienced consistent growth over recent years. The market is projected to expand from $5.15 billion in 2024 to $5.4 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.0%. This historical expansion is largely due to factors such as the influence of the smoking epidemic, progress in pharmaceutical treatments, the availability of pulmonary rehabilitation programs, enhanced diagnostic instruments, and increased public awareness and education.

The emphysema treatment market is projected to experience robust expansion over the coming years. This market is forecast to reach $7.28 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. Several factors are driving this anticipated growth, including the increasing aging population, the adoption of personalized treatment strategies, broader availability of therapies, an emphasis on managing symptoms, and the rise of collaborative healthcare frameworks. Key trends shaping the market during this period encompass the investigation into gene therapies, efforts in patient education and empowerment, the incorporation of artificial intelligence (AI), enhanced access to treatment options, and the ongoing development of long-acting medications.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Strategic Drivers Are Accelerating The Emphysema Treatment Market Expansion?

The increasing incidence of chronic obstructive pulmonary disease (COPD) cases is projected to boost the expansion of the emphysema treatment market moving forward. Chronic obstructive pulmonary disease (COPD) refers to a group of conditions that impair airflow and cause breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are crucial in mitigating the progression of Chronic Obstructive Pulmonary Disease (COPD) as they focus on managing symptoms, restoring lung function, and slowing down disease advancement. For illustration, reports published in June 2024 by the Australian Institute of Health and Welfare (AIHW), an Australia-based agency, estimated that around 638,000 people, or 2.5% of the population in Australia, were living with chronic obstructive pulmonary disease (COPD) in 2022. By 2023, COPD’s share of the overall disease burden had increased to 3.6%, representing 50% of the total burden linked to respiratory conditions. Moreover, in 2022, COPD was the underlying cause of 7,691 deaths, which corresponds to 29.6 deaths per 100,000 people and accounts for 4.0% of all fatalities in the country. Therefore, the growing prevalence of chronic obstructive pulmonary disease (COPD) cases is a significant driver for the emphysema treatment market.

What Is The Detailed Segment Distribution Of The Emphysema Treatment Market?

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

How Are Global Trends Impacting The Development Of The Emphysema Treatment Market?

Leading companies within the emphysema market are actively developing minimally invasive procedures for patients to secure a competitive advantage. These minimally invasive procedures are defined as medical or surgical interventions carried out with minimal disruption to the body’s natural structures. For example, Adena Health System, a US-based healthcare firm, introduced the Zephyr Valve surgery in January 2022. This procedure is a minimally invasive option that provides an alternative to conventional lung volume reduction surgery for individuals experiencing lung hyperinflation, a common condition in emphysema and COPD. The innovative method involves inserting small, one-way Zephyr Valves into the lung’s airways using a bronchoscope. These valves help release trapped air, prevent further accumulation, and allow healthier lung areas to expand, ultimately leading to improved breathing.

Who Are The Major Stakeholders Operating In The Emphysema Treatment Market?

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Emphysema Treatment Market?

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

Browse Through More Reports Similar to the Global Emphysema Treatment Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Point Of Entry Water Treatment Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-entry-water-treatment-systems-global-market-report

Point Of Use Water Treatment Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-use-water-treatment-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795